FDA is committed to protecting national health and security. We are working to foster the development and availability of medical products that will be needed to counter a public health emergency, no matter its origin.
The FDA Medical Countermeasures Initiative (MCMi) mission includes:
A robust MCM regulatory science program that creates the data necessary to support regulatory decision-making
A collaborative effort to modernize the legal, regulatory and policy framework establishes effective policies and mechanisms to facilitate timely access to available MCMs
A professional development program that helps FDA meets the regulatory challenges posed by new science and technology developments